NASDAQ:NKTR
Nektar Therapeutics Stock News
$1.64
-0.0200 (-1.20%)
At Close: May 24, 2024
Why Is Nektar (NKTR) Down 51.9% Since Last Earnings Report?
12:56pm, Thursday, 30'th Mar 2023
Nektar (NKTR) reported earnings 30 days ago. What's next for the stock?
Nektar (NKTR) Upgraded to Buy: Here's Why
01:45pm, Friday, 24'th Mar 2023
Nektar (NKTR) might move higher on growing optimism about its earnings prospects, which is reflected by its upgrade to a Zacks Rank #2 (Buy).
5 Best and Worst Performing Small-Cap Stocks in February 2023
10:51pm, Monday, 13'th Mar 2023
Small-cap stocks, in general, are more domestic in nature, and this protects them from geopolitical and foreign exchange risks.
Why Is Nektar Therapeutics (NKTR) Stock Down 39% Today?
08:56am, Friday, 24'th Feb 2023
Nektar Therapeutics (NASDAQ: NKTR ) stock is taking a beating on Friday following the release of Phase 2 clinical trial data. This Phase 2 study had Nektar Therapeutics testing the effectiveness of re
Nektar stock drops more than 30% after study involving lupus treatment will not go forward
05:24pm, Thursday, 23'rd Feb 2023
Shares of Nektar Therapeutics NKTR, -1.66% plunged more than 30% in the extended session Thursday after the biopharma company reported that a study did not meet goals and that partner Eli Lilly & Co.
Meet The 5 Unlucky Investors Who Loaded Up On Year's Worst Stocks
08:00am, Monday, 19'th Dec 2022
Few investors can hit all the year's best S&P 500 stocks. But some were unlucky enough to own big stakes of the worst.
Nektar Therapeutics: Recovery Seems To Be A Mirage
05:50pm, Friday, 18'th Nov 2022
Once bearish sentiment ends, good quality biotech stocks will bounce back, but Nektar Therapeutics probably won't. Funds continue to dwindle while projects are far from commercialization stage.
Nektar's (NKTR) Q3 Earnings and Revenues Beat Estimates
02:20pm, Friday, 04'th Nov 2022
Nektar (NKTR) reports encouraging third-quarter 2022 results. The narrower-than-expected loss is on account of lower operating expenses incurred during the quarter.
Nektar Therapeutics (NKTR) Q3 2022 Earnings Call Transcript
11:15pm, Thursday, 03'rd Nov 2022
Nektar Therapeutics (NASDAQ:NKTR ) Q3 2022 Earnings Conference Call November 3, 2022 5:00 PM ET Company Participants Vivian Wu - Director, Investor Relations and Corporate Affairs Howard Robin - Presi
Nektar Therapeutics (NKTR) Reports Q3 Loss, Tops Revenue Estimates
08:20pm, Thursday, 03'rd Nov 2022
Nektar (NKTR) delivered earnings and revenue surprises of 48.94% and 1.35%, respectively, for the quarter ended September 2022. Do the numbers hold clues to what lies ahead for the stock?
SAN FRANCISCO , Oct. 25, 2022 /PRNewswire/ -- Nektar Therapeutics (Nasdaq: NKTR) will announce its financial results for the third quarter 2022 on Thursday, November 3, 2022, after the close of U.S.-b
PureTech Health and Nektar Therapeutics end tie-up talks
05:13am, Tuesday, 11'th Oct 2022
PureTech Health (LSE:PRTC, NASDAQ:PRTC, OTC:PTCHF) PLC and Nektar Therapeutics (NASDAQ:NKTR) said they have mutually agreed to terminate discussions regarding a possible combination of the two compani
3 Penny Stocks Trading Strategies You Need to Consider
11:00am, Saturday, 08'th Oct 2022
Check these penny stocks trading strategies out this week The post 3 Penny Stocks Trading Strategies You Need to Consider appeared first on Penny Stocks to Buy, Picks, News and Information | PennyStoc
Best Penny Stocks To Buy Now? 4 Biotech Stocks To Watch
02:06pm, Friday, 07'th Oct 2022
Best penny stocks to buy? Biotech penny stocks are heating up & these 4 might be worth watching now.
PureTech Health confirms ‘possible combination' with Nektar Therapeutics
03:36am, Friday, 07'th Oct 2022
PureTech Health (LSE:PRTC, NASDAQ:PRTC, OTC:PTCHF) PLC has confirmed that it is in talks about a possible tie-up with Nektar Therapeutics (NASDAQ:NKTR), Inc. Responding to press speculation, PureTec